Absorb Bioresorbable Vascular Scaffolds vs. XIENCE Everolimus-Eluting Stents: Are Clinical Outcomes Different for Men and Women?

被引：0
|
作者：
Kereiakes, Dean [1 ]
Ellis, Stephen [2 ]
Gao, Runlin [3 ]
Kimura, Takeshi [4 ]
Onuma, Yoshinobu [5 ]
Piard-Ruster, Karine [6 ]
Zhang, Yunlong [6 ]
Koo, Kai [6 ]
Serruys, Patrick [7 ]
Stone, Gregg [8 ]
机构：
[1] Christ Hosp, Cincinnati, OH 45219 USA
[2] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] CAMS&PUMC, Fuwai Hosp, Beijing, Peoples R China
[4] Kyoto Univ Hosp, Kyoto, Japan
[5] Erasmus MC, Thoraxctr, Rotterdam, Netherlands
[6] Abbott Vasc, Santa Clara, CA USA
[7] Imperial Coll, London, England
[8] Columbia Univ, NewYork Presbyterian Hosp, Med Ctr, Cardiovasc Res Fdn, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 18期
关键词：
D O I：
10.1016/j.jacc.2016.09.550
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-415
引用
收藏
页码：B168 / B168
页数：1
相关论文
共 50 条
  • [31] Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials
    Cassese, Salvatore
    Byrne, Robert A.
    Juni, Peter
    Wykrzykowska, Joanna J.
    Puricel, Serban
    Ndrepepa, Gjin
    Schunkert, Heribert
    Fusaro, Massimiliano
    Cook, Stephane
    Kimura, Takeshi
    Henriques, Jose P. S.
    Serruys, Patrick W.
    Windecker, Stephan
    Kastrati, Adnan
    [J]. EUROINTERVENTION, 2018, 13 (13) : 1565 - 1573
  • [32] Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial
    Kraak, Robin P.
    Tijssen, Ruben Y. G.
    van Dongen, Ivo M.
    Elias, Joelle
    Hofma, Sjoerd H.
    van der Schaaf, Rene J.
    Arkenbout, E. Karin
    Weevers, Auke
    Tijssen, Jan G. P.
    Piek, Jan J.
    de Winter, Robbert J.
    Henriques, Jose P. S.
    Wykrzykowska, Joanna J.
    [J]. EUROINTERVENTION, 2020, 16 (11) : E904 - E912
  • [33] ABSORB everolimus-eluting bioresorbable vascular scaffold systems for the sealing of unstable plaques
    Gori, T.
    Qu, Z.
    Muxel, S.
    Hink, U.
    Schulz, E.
    Wenzel, P.
    Jabs, A.
    Munzel, T.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 485 - 485
  • [34] Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
    Kerkmeijer, Laura S. M.
    Renkens, Mick P. L.
    Tijssen, Ruben Y. G.
    Hofma, Sjoerd H.
    van der Schaaf, Rene J.
    Arkenbout, E. Karin
    Weevers, Auke P. J. D.
    Garcia-Garcia, Hector M.
    Kraak, Robin
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    de Winter, Robbert J.
    Wykrzykowska, Joanna J.
    [J]. EUROINTERVENTION, 2022, 17 (16) : 1340 - +
  • [35] Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry
    Hoppmann, P.
    Kufner, S.
    Cassese, S.
    Wiebe, J.
    Schneider, S.
    Pinieck, S.
    Scheler, L.
    Bernlochner, I.
    Joner, M.
    Schunkert, H.
    Laugwitz, K-L.
    Kastrati, A.
    Byrne, R. A.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (05) : 822 - 829
  • [36] Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trial
    Tanabe, Kengo
    Popma, Jeffrey J.
    Kozuma, Ken
    Saito, Shigeru
    Muramatsu, Toshiya
    Nakamura, Sunao
    Namiki, Atsuo
    Morino, Yoshihiro
    Hagiwara, Nobuhisa
    Uematsu, Masaaki
    Kawasaki, Tomohiro
    Fujii, Kenshi
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Ying, Shihwa
    Kusano, Hajime
    Stone, Gregg W.
    Kimura, Takeshi
    [J]. EUROINTERVENTION, 2018, 14 (09) : E1020 - E1028
  • [37] One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic scents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials
    Costa, Jose de Ribamar, Jr.
    Abizaid, Alexandre
    Bartorelli, Antonio L.
    Whitbourn, Robert
    Jepson, Nigel
    Perin, Marco
    Steinwender, Clemens
    Stuteville, Marrianne
    Ediebah, Divine
    Sudhir, Krishnankutty
    Serruys, Patrick W.
    [J]. EUROINTERVENTION, 2016, 12 (10) : 1255 - 1262
  • [38] ECONOMIC OUTCOMES OF BIORESORBABLE VASCULAR SCAFFOLDS VERSUS EVEROLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION: ONE YEAR RESULTS FROM THE ABSORB III TRIAL
    Baron, Suzanne
    Lei, Yang
    Vilain, Katherine
    Magnuson, Elizabeth
    Kereiakes, Dean
    Ellis, Stephen
    Stone, Gregg
    Cohen, David
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 19 - 19
  • [39] Malapposition, underexpansion and edge dissection in everolimus-eluting bioresorbable vascular scaffolds and metallic everolimus-eluting stents-a comparison based on Optical Coherence Tomography
    Dalos, D.
    Gangl, C.
    Roth, C.
    Krenn, L.
    Scherzer, S.
    Vertesich, M.
    Kreiner, G.
    Lang, I.
    Delle-Karth, G.
    Neunteufl, T.
    Christ, G.
    Berger, R.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 : S98 - S99
  • [40] Long-Term Outcomes of Absorb Bioresorbable Vascular Scaffold vs. Everolimus-Eluting Metallic Stent - A Randomized Comparison Through 5 Years in Japan -
    Kozuma, Ken
    Tanabe, Kengo
    Hamazaki, Yuji
    Okamura, Takayuki
    Ando, Jiro
    Ikari, Yuji
    Nakagawa, Yoshihisa
    Kusano, Hajime
    Ediebah, Divine
    Kimura, Takeshi
    [J]. CIRCULATION JOURNAL, 2020, 84 (05) : 733 - 741
12345